An Early and Rare Second Malignancy in A Treated Glioblastoma Multiforme: Is It Radiation or Temozolomide?

Shina Goyal

Open source

DOI
10.7860/jcdr/2015/13588.5833
Published
2015
Container
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Publisher
JCDR Research and Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7860/jcdr/2015/13588.5833,
  title = {An Early and Rare Second Malignancy in A Treated Glioblastoma Multiforme: Is It Radiation or Temozolomide?},
  author = {Shina Goyal},
  year = {2015},
  journal = {JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH},
  doi = {10.7860/jcdr/2015/13588.5833},
  url = {https://doi.org/10.7860/jcdr/2015/13588.5833}
}

RIS

TY  - JOUR
TI  - An Early and Rare Second Malignancy in A Treated Glioblastoma Multiforme: Is It Radiation or Temozolomide?
AU  - Shina Goyal
PY  - 2015
JO  - JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
DO  - 10.7860/jcdr/2015/13588.5833
UR  - https://doi.org/10.7860/jcdr/2015/13588.5833
ER  - 

APA

Goyal, S. (2015). An Early and Rare Second Malignancy in A Treated Glioblastoma Multiforme: Is It Radiation or Temozolomide?. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2015/13588.5833

Source records